Abbott recently received FDA approval for TriClip, a variation of the MitraClip system for the heart's tricuspid valve. Before the FDA said yes to MitraClip in 2013, agency staffers pushed back.

Abbott Laboratories has announced that its ... than expected for surgery (4.8% for patients treated with the MitraClip system versus 18.2% predicted surgical mortality) and an implant success ...

In severe cases, surgery can repair or replace the valve. If patients are not candidates for surgery, doctors can implant a clothespin-like device called a MitraClip that helps the valve close ...